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Abstract
Introduction
Role of hair dyes in the etiology of breast cancer has occasionally raised concern but previ-
ous research has concluded with mixed results. Remnants of prohibited aromatic amines
have been found in many hair dye products, and elevated levels of DNA-adducts of these
amines have been detected from breast epithelial cells of hair dye users. However, the
IARC working group has concluded that there is inadequate evidence for carcinogenicity of
personal hair dye use and limited evidence in experimental animals for carcinogenicity of
hair colorants.
Material and Methods
We investigated whether the use of hair dyes is associated with breast cancer risk in
women. The study design was a retrospective population-based case-control study in Fin-
land, with a self-administered questionnaire from 6,567 breast cancer patients, aged 22–60
years and diagnosed in 2000–2007, and their 21,598 matched controls. We report odds
ratios (OR) with 95% confidence interval (95% CI) from a conditional logistic regression
model applied to the frequency matched sets of cases and controls. Bias-adjusted odds
ratios from the sensitivity analysis are also presented.
Results
After adjusting for potential confounders, the odds of breast cancer increased by 23% (OR:
1.23, 95% CI: 1.11–1.36) among women who used hair dyes compared to those who did
not. In women born before 1950 an increase of 28% was noted (OR: 1.28, 95% CI: 1.10–
1.48). We also observed a significant trend between the OR and cumulative use of hair
dyes (P: 0.005). Bias-adjusted odds ratios varied between 1.04 and 2.50.
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Conclusions
Our results suggest that use of hair dyes is associated with breast cancer incidence. The
impact on public health may be substantial due to vast popularity of hair coloring in modern
societies. It should be noted that regardless of all efforts, a possibility of bias cannot defini-
tively be ruled out and use of a prospective design is warranted. Based on the present
results, it may be concluded however that safety of hair dyes in relation to breast cancer
cannot yet be fully acknowledged and lack of external safety assessment within the cosmet-
ics industry is of major concern.
Introduction
It has been suggested that certain chemical compounds, especially aromatic amines that are
often present in commercial hair dyes and bleaches, may play a role in the etiology of some
human cancers. Research results have though been inconclusive.[1] According to the estimate
of the European Commission, some 60% of women and 5–10% of men in Europe use hair dyes
on average six to eight times per year [2]. Considering the extensive use of hair dyes, even a
small increase in risk may have an immense impact on public health.
Hair dyes can roughly be categorized as permanent, oxidative hair dyes and semi-perma-
nent and temporary dyes, the latter two being mainly non-oxidative[3]. Permanent hair dyes
are the most commonly used. They consist of colorless dye intermediates and so called dye
couplers, which are derivatives of aniline (phenyl amine) and give the specific color wanted. In
the presence of hydrogen peroxide, the intermediates and couplers react with one another to
form pigment molecules. Darker colors are formed by using higher concentrations of interme-
diates. Non-oxidative semi-permanent and temporary hair dyes include colored compounds
that stain hair directly.[4,5]. Hair coloring has long traditions, dating back thousands of years.
Oxidative hair dyes were introduced in the end of the 19th century, before which natural dyes,
such as henna dominated. In the 1970 and 1980’s, a variety of new hair dye substances were
brought to the market, while at the same time concerns were raised on the safety of certain dye-
ing chemicals. This led to banning of several potential carcinogenic substances in the EU, but
not in the US [5].
P-Phenylenediamine (PPD) is among the most commonly used hair dye compounds [4]. It
is hypothesized that some of the potential carcinogenic effect of PPD is due to its contamina-
tion with 4-aminobiphenyl (4-ABP, CAS no. 92-67-1) during the production process. 4-ABP
has been classified as carcinogenic to humans by the International Agency for Research on
Cancer (IARC) [6]. Its use was prohibited in cosmetic products in the European Union only in
2004, even though sale to general public was forbidden already in 1989 and manufacture in
1998 [6–7]. 4-ABP is also strictly regulated e.g in the United States [8]. It is specifically of con-
cern that despite of the legislative restrictions, 4-ABP has been found in many of the hair dye
products currently on the market with concentrations above the approved limits [9,10].
The mechanism of a possible association between hair dye use and breast cancer, and most
specifically of the potential tumorigenesis induced by 4-ABP, is not clear. 4-ABP has been sug-
gested to have an ability to produce mutations in the human genome[5]. Knowing the signifi-
cant etiologic role of estrogen in breast cancer, one possible pathway could also be through
estrogenic activity of 4-ABP [11]. IARC working group 2008 evaluated the main route of expo-
sure to hair dye components being dermal absorption regarding both occupational exposure as
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well as personal use, airborne exposure playing a smaller role. The monograph concluded that
there was insufficient evidence on the carcinogenicity of hair dyes. [5].
We investigated the relationship of personal hair dye use and occurrence of breast cancer in
a population-based series of some 6 800 breast cancer cases and 21 600 controls. The main
objective was to determine whether the use of hair dyes is associated with the risk of breast
cancer.
Material and Methods
The study design was a retrospective, frequency matched population-based case-control study
with a questionnaire conducted in 2009. Case ascertainment was done in December 2008 from
the population-based, nationwide cancer registry, covering close to 100% of solid tumors [12].
All women in Finland aged 22 to 60 years and diagnosed with first in-situ or invasive breast
cancer between 1st January 2000 and 31st December 2007 were considered eligible (N = 14
815). Age-matched controls were sampled from the central population register (N = 64 353).
For the purpose of this study, re-matching by birth year was conducted to match the cases and
controls in an exact ratio of 1:4 and the surplus of controls and cases were randomly excluded
from the appropriate birth year cohorts.
Of the 14 815 breast cancer cases identified from the cancer registry, 1550 had died before
the start of the study, leaving 13 265 cases in the sample. After re-matching the cases and con-
trols by birth year, 10 448 women with breast cancer were left in the data. Of these, 951 were
excluded due to any previous malignancy, leaving 9 537 cancer cases for the study, out of
which 6567 responded to the questionnaire (69%). With respect to morphology of the cancers,
5248 (80%) were ductal carcinomas, of which 4758 (91%) invasive and 1022 (16%) lobular car-
cinomas, of which 1002 (98%) invasive. The remaining 4% (N = 297) included cases of medul-
lary, mucinous, tubular, and other infrequent types of breast cancer, or cases where
morphology could not be clearly specified. From all breast cancer cases in the study, 99% were
based on histological confirmation.
The questionnaire Women’s Health and Use of Hormones was initially developed to
address the association between the use of hormonal intrauterine device and breast cancer [13]
and it also served in this study as the source of exposure information. The questionnaire was
self-administered and identical for cases and controls. It mapped out a large variety of known
risk factors of breast cancer, such as parity, age at first birth, family history of breast cancer,
menarche age, alcohol use, body mass index (BMI) and level of education, as well as several
other behavioral and lifestyle-related factors.
The exposure of primary interest in this study was the use of hair dyes. The respondents
were asked to estimate the cumulative number of hair dye episodes during life, age at first use
and the types of dyes used. Regarding the total number of hair dye episodes during life, the
response options were categorized as: Never, 1–2 times, 3–9 times, 10–34 times, 35–89 times or
90 times or more. In a pooled analysis, women reporting using hair dyes ‘Never’ or ‘1–2 times’
in their lifetime were classified as never-users, all other categories counting as ever-users. Age
at first dye was categorized as: Under 20 years of age, 20–29 years, 30–39 years, and 40 years or
older. The different dye types were defined as: ‘Temporary’ = a color that rinses off at first or
few washes, ‘Semi-permanent’ = a color that rinses off after several washes, ‘Permanent’ = a
color that does not wash off, ‘Bleach’ = the hair was bleached before coloring and ‘Partial’ = the
hair was only partially dyed, e.g. highlighted. The frequency of dyeings in each of the type-spe-
cific categories was classified as Never, Rarely, Quite Often, Often.
We report odds ratios (OR), with their 95% confidence intervals (CI) from the conditional
logistic regression model applied to frequency matched study design. Potential confounding
Breast Cancer and Use of Hair Dyes
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factors, including parity, age at first birth, family history of breast cancer, menarche age, use of
hormonal contraceptives, physical activity, alcohol use, BMI and education were included in
the multivariate adjusted model, as suggested by the step wise model search. We tested the
trend in the log-ORs (dose-response) of the number of hair dye episodes and the odds of breast
cancer by treating the number of episodes as a continuous variable in the logistic regression.
Attributable fraction in the exposed represents the magnitude of the role of hair dye use in
breast cancer risk in the exposed and was calculated with a formula presented by Greenland
((OR-1)/OR) x 100) [14]. To identify differences in the odds of breast cancer in women with
different type of hair dye exposure history, results stratified by birth year cohorts are presented.
Subjects with missing values in any of the covariates in the fitted model were excluded.
Owing to comprehensive cancer information from the population based cancer registry in
Finland, the coverage of cancer diagnoses was close to complete [12] and the role of a possible
selection/ascertainment bias was considered to be negligible. A deterministic sensitivity analy-
sis was conducted in an effort to assess other potential sources of bias affecting the observed
findings. Misclassification of the main exposure of interest (hair dye use), non-response bias
with respect to hair dye use and a role of socio-economic status as an uncontrolled confounder
were considered and bias-adjusted odds ratios with bias percentages are presented.
The data was analyzed using R, version 3.1.1., with packages Epi (1.1.67), car (2.0–22) and
Survival (2.37–7). The sensitivity analysis was performed with Stata version 12, using the Epi-
sensi-command, as introduced by Orsini and colleagues [15].
The study was approved by the ethical committee of HUS (Helsinki and Uusimaa Health
district, no. 322/E0/2007) and permission for data linkage was obtained from the National
Institute of Health andWelfare (THL, former STAKES, no. 2920/605/2008, extension permis-
sion no. THL/221/5.05.00/2014). Permission to contact the patients was issued by the senior
physician of the appropriate hospital. The aims and objectives of the study were explained at
the cover letter of the questionnaire, and returning of the filled questionnaire was considered
as an informed consent.
Results and Discussion
As of the controls, 41 978 subjects remained in the sample after the re-matching, out of the 64
353 originally sampled. Of these 23 114 responded to the questionnaire (55%). A previous
malignancy was reported by 1516 controls and these were excluded, leaving 21 598 controls in
the analytical data set.
Distribution of the diagnostic age did not differ between the cases who answered to the
questionnaire and those who did not, being 52 years in both groups. Median age at the time
of the questionnaire was 57.5 years among the responded cases as well as controls. As
expected, cases had a higher response rate (69%) than the controls (55%). Age distributions
are presented in Table 1. Median diagnostic age of breast cancer cases died before the ques-
tionnaire was 51 years. Regarding morphology, 76% of these were ductal and 17% lobular car-
cinomas. As for staging, 76% of were metastasized cancers, in contrast to 39% of the cancers
of the respondent cases.
Prevalence of other breast cancer risk factors according to hair dye use (24 479 users and 3
316 non-users) are shown in Table 2. The popularity of hair coloring varied along the calendar
time. While 84% of the women born before 1950 had ever used hair dyes, the corresponding
figure among women born in or after 1960 was 92%. Hair dye users reported more often ever-
use of alcohol, with only 7% of them reporting never-use, compared to never-use of 27%
among the non-hair dye users. Hair dye users also smoked more often (ever-smoking of 46%
vs. 29%) and were more often users of hormonal contraceptives than non-hair dye users (ever-
Breast Cancer and Use of Hair Dyes
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Table 1. Numbers and percentages of the responded and non-responded breast cancer cases and controls andmedian ages of the cases at diag-
nosis, according to birth-year cohorts.
Birth year Contacted (%
of total)
Cases
Contacted (%
of total)
Controls
Responded (%
of total) Cases
Responded (%
of total)
Controls
Non-
resp. (%
of total)
Cases
Non-resp.
(% of total)
Controls
Resp.
rate
Cases
Resp. rate
Controls
Median
diag. age
(in resp.
cases)
Before 1950 3504 (37%) 15 067 (37%) 2446 (37%) 7876 (36%) 1058
(36%)
7191 (38%) 70 52 58 years
Between
1950 and
1959
4366 (46%) 18 374 (45%) 3004 (46%) 9994 (46%) 1362
(46%)
8380 (44%) 69 54 50 years
In or after
1960
1667 (17%) 7021 (17%) 1117 (17%) 3728 (17%) 550
(19%)
3293 (17%) 67 53 41 years
Total 9537 40 462 6567 21 598 2970 18 864 69 53 NA
Median
diag. age of
the cases
52 years NA 52 years NA 52 years NA NA NA
doi:10.1371/journal.pone.0135190.t001
Table 2. Selected characteristics of hair dye users and non-users.
Hair dye users (N: 24 479) Non-hair dye users (N: 3316)
Number %* Number %*
Birth cohort
Before 1950 8447 841 1657 161
1950–1959 11586 902 1287 102
In or after 1960 4446 923 372 83
Alcohol use
Never 1781 7 887 27
Occasionally 11610 48 1544 47
 3 times/week 9703 40 735 22
 4 times/week 1204 5 127 4
Missing 181 1 23 1
Smoking history
Never 12935 53 2298 69
Ever 11326 46 978 29
Missing 218 1 40 1
Education
 9 yrs (Basic) 13124 54 1893 57
10–12 yrs (High school) 2272 9 273 8
13–16 yrs (Polytech.) 5629 23 603 18
17 yrs (Univ.) 3316 14 520 16
Missing 138 1 27 1
Past use of hormonal contraceptives
Never 5771 24 1501 45
Ever 18526 76 1778 54
Missing 182 1 37 1
Past use of hormone treatment therapy
Never 14422 59 2168 65
Ever 9477 39 1037 31
Missing 580 2 111 3
(Continued)
Breast Cancer and Use of Hair Dyes
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using 76% vs. 54%), while non-hair dye users were more often nulliparous (18% vs. 10%) and
single (12% vs. 7%).
The odds of breast cancer was significantly increased (OR 1.23, 95% CI: 1.11–1.36), when
comparing ever vs. never users of hair dyes after adjusting for other risk factors (Table 3). Con-
sidering the cumulative number of hair dye episodes, the odds ratio ranged from 1.07 (1–2 dye
episodes) to 1.31 (35–89 dye episodes) and a statistically significant trend was observed
(P = 0.005). Early age at first dye (20–29) was associated with higher odds of breast cancer
when compared to those started at 40 years of age or later (OR 1.14, 95% CI: 1.05–1.25). The
association was not, however, seen in those with a first dye episode before the age 20 (OR 1.06,
95% CI 0.96–1.16). In a pooled estimate (starting age<30 vs.30), an increase of 7% was
observed (OR: 1.07, 95% CI: 1.01–1.14) among women who had started using hair dyes before
the age 30.
Table 2. (Continued)
Hair dye users (N: 24 479) Non-hair dye users (N: 3316)
Number %* Number %*
Parity
No 2455 10 607 18
Yes 21931 90 2692 81
Missing 93 0 17 1
Family history of breast cancer
No 21151 86 2830 85
Yes 2985 12 427 13
Missing 343 1 59 2
Marital status
Single 1606 7 395 12
Married or Common-Law
Marriage 17884 73 2316 70
Divorced or separated 3711 15 362 11
Widowed 1185 5 224 7
Missing 93 0 19 1
Body Mass Index
<25 kg/m2 10380 42 1310 40
25–29.9 kg/m2 8122 33 1035 31
30 kg/m2 4344 18 667 20
Missing 1633 7 304 9
Physical activity
None 1673 7 347 10
2–3 times/month 5664 23 816 25
Once/week 6723 27 802 24
Several times/week 10040 41 1275 38
Missing 379 2 76 2
*Percentages rounded to 0 decimal and may not always add up to 100
No. of missing values as for hair dye use: 370
1Of those born before 1950
2Of those born between 1950 and 1959
3Of those born in or after 1960
doi:10.1371/journal.pone.0135190.t002
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Table 3. Results from the analysis of the association between hair dye use and odds of breast cancer*.
Cases Controls OR Univariate OR Multivariate
Pooled ever-use
Ever 5793 18686 1.15 (1.06–1.24) 1.23 (1.11–1.36)
Never¥ 702 2614 1.0 1.0
NA 72 298
Number of dyes
0 412 1510 1.0 1.0
1–2 290 1104 0.97 (0.83–1.13) 1.07 (0.88–1.29)
3–9 829 2737 1.11 (0.98–1.25) 1.19 (1.03–1.39)
10–34 2153 6989 1.13 (1.02–1.26) 1.28 (1.12–1.47)
35–89 1714 5305 1.18 (1.06–1.32) 1.31 (1.14–1.51)
 90 1097 3655 1.11 (0.99–1.24) 1.25 (1.08–1.45)
NA 72 298
Trend P = 0.0005 P = 0.00006
Age at ﬁrst dye
< 20 1539 5212 1.00 (0.92–1.08) 1.06 (0.96–1.16)
20–29 2061 6453 1.07 (0.99–1.15) 1.14 (1.05–1.25)
30–39 1282 4171 1.03 (0.95–1.12) 1.06 (0.97–1.16)
 40 1211 4017 1.0 1.0
NA 474 1745
Pooled age
<30 3600 11665 1.02 (0.97–1.08) 1.07 (1.01–1.14)
30 2493 8188 1.0 1.0
NA 474 1745
Trend P = 0.4150 P = 0.0196
Temporary dye†
Ever 573 1726 1.22 (1.09–1.36) 1.32 (1.16–1.52)
Never 4074 12769 1.18 (1.09–1.28) 1.27 (1.14–1.41)
Non-hair dye user 702 2614 1.0 1.0
NA 1218 4489
Semi-permanent dye
Ever 2524 7716 1.21 (1.11–1.32) 1.31 (1.17–1.46)
Never 2646 8429 1.17 (1.07–1.27) 1.25 (1.12–1.39)
Non-hair dye user 702 2614 1.0 1.0
NA 695 2839
Permanent dye
Ever 3059 9769 1.17 (1.07–1.27) 1.25 (1.12–1.39)
Never 2273 7180 1.17 (1.07–1.27) 1.24 (1.11–1.38)
Non-hair dye user 702 2614 1.0 1.0
NA 533 2035
Bleach
Ever 282 881 1.19 (1.04–1.37) 1.25 (1.06–1.48)
Never 4705 14752 1.18 (1.09–1.28) 1.27 (1.14–1.41)
Non-hair dye user 702 2614 1.0 1.0
NA 878 3351
Partial dye
Ever 2153 6686 1.20 (1.10–1.30) 1.28 (1.14–1.43)
Never 3247 10312 1.17 (1.07–1.27) 1.25 (1.12–1.39)
(Continued)
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Regarding the different types of hair dyes, the odds ratios were increased with all types,
when compared to non-hair dye users. The highest estimates were obtained for women who
reported to have used temporary and/or semi-permanent dyes, with 32% and 31% increase in
the odds of breast cancer (OR: 1.32, 95% CI: 1.16–1.52 and OR: 1.31, 95% CI: 1.17–1.46),
respectively.
When including only invasive breast cancers in the analysis, a 21% increase in the estimated
odds ratio was noted (OR: 1.21, 95% CI: 1.09–1.34, results not shown). In age group specific
analysis, the odds ratio regarding ever vs. never use of hair dyes was the most increased in
women born before 1950 (OR: 1.28, 95% CI: 1.10–1.48, Table 4). When stratifying the analysis
by the reported menopausal status, increased odds ratio for ever-use of hair dyes was observed
for post-menopausal women only (OR 1.25, 95% CI: 1.10–1.43 in contrast to OR 1.19, 95% CI:
0.81–1.75 for pre-menopausal women, results not shown). The attributable fraction of hair
dyeing on breast cancer risk among the exposed was 18.7% (95% CI: 9.9%-26.5%) when esti-
mated from the odds ratio of 1.23 (95% CI: 1.11–1.36). To reduce the risk of recall bias, we also
did the analysis restricted to cases diagnosed more recently. We obtained an odds ratio of 1.30
(95% CI: 0.96–1.76) when including cases diagnosed in 2007 and OR 1.31 (95% CI: 1.07–1.61)
when including diagnostic years 2006 and 2007.
The bias-adjusted odds ratios and the parameters used as priors in the sensitivity analysis
are presented in S1 Appendix. When adjusted for potential differential misclassification of hair
dye use as an exposure, simulated bias-adjusted OR of 2.50 was observed, indicating 54%
downward bias. Regarding bias due to non-response with respect to hair dye use, an adjusted
OR of 1.04 was observed, suggesting 11% upward bias. With respect to uncontrolled confound-
ing, a bias-adjusted OR of 1.46 (-21% bias) was estimated when the level of education was used
as a surrogate to assess the role of socio-economic status.
Users of hair dye had a significant, 23% increased odds of breast cancer compared to non-
users. The highest association was observed in women born before 1950 (28% increase in the
odds). Furthermore, a substantial amount (19%) of the new breast cancer cases in women 60
years of age or less can potentially be attributable to the use of hair dye products.
The estimates did not significantly vary between different types of dyes. Most interestingly,
temporary and semi-permanent dyes seemed to have greatest impact in the odds of breast can-
cer. Permanent hair colours containing higher concentrations of intermediates and oxidative
agents have previously been thought to possess the most potentially hazardous effects. Never-
theless, many of the modern semi-permanent dyes contain a peroxidising agent and may thus
be considered to act as permanent dyes with lower oxidative agent concentrations. Also, semi-
permanent colours may contain potentially carcinogenic substances, as many of them contain
an azo bond that after cleavage may result into the release of aromatic amines [16]. Even
Table 3. (Continued)
Cases Controls OR Univariate OR Multivariate
Non-hair dye user 702 2614 1.0 1.0
NA 465 1986
TOTAL 6567 21 598
*Odds ratios with 95% conﬁdence interval are reported, multivariate model adjusted for birth year, parity, age at ﬁrst birth, family history of breast cancer,
menarche age, use of hormonal contraceptives, physical activity, alcohol use, body mass index and level of education.
¥Women reporting using hair dyes ‘Never’ or ‘1–2 times’ in their lifetime were classiﬁed as never-users, all other categories counting as ever-users.
† Hair dye use according to the type of the dye was grouped into never and ever-users, answers ‘Rarely’ or ‘Never’ falling into category of never-users and
‘Often’ and ‘Quite often’ into ever-users. Non-users of hair dyes as deﬁned in pooled ever vs. never-use were used as a reference category.
doi:10.1371/journal.pone.0135190.t003
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Table 4. Results from themultivariate analysis of the association between breast cancer and hair dye use by birth year*.
Born before 1950 Born 1950–1959 Born 1960 or after
N: Ca 2446, Co 7876 N: Ca 3004, Co 9994 N: Ca 1117, Co 3728
Cases/Controls OR (CI 95%) Cases/Controls OR (CI 95%) Cases/Controls OR (CI 95%)
Pooled ever-use
Ever 2044/6403 1.28 (1.10–1.48) 2709/8877 1.20 (1.02–1.40) 1040/3406 1.14 (0.85–1.54)
Never¥ 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 43/175 21/104 8/19
No. of dyes
0 227/790 1.0 148/561 1.0 37/159 1.0
1–2 132/508 0.96 (0.72–1.26) 126/452 1.25 (0.92–1.68) 32/144 0.89 (0.51–1.57)
3–9 352/1162 1.19 (0.96–1.48) 359/1157 1.27 (0.99–1.63) 118/418 0.97 (0.61–1.54)
10–34 751/2423 1.26 (1.03–1.53) 1016/3301 1.34 (1.07–1.68) 386/1265 1.10 (0.71–1.68)
35–89 553/1601 1.30(1.06–1.60) 804/2625 1.35 (1.07–1.70) 357/1079 1.15 (0.75–1.77)
 90 388/1217 1.26 (1.01–1.56) 530/1794 1.34 (1.06–1.70) 179/644 0.96 (0.61–1.51)
NA 43/175 21/104 8/19
Age at ﬁrst dye
<20 425/1464 1.03 (0.89–1.18) 659/2269 1.04 (0.91–1.19) 455/1479 1.09 (0.69–1.71)
20–29 644/1900 1.19 (1.05–1.36) 989/3101 1.12 (0.99–1.27) 428/1452 1.09 (0.70–1.70)
30–39 469/1405 1.17 (1.01–1.34) 656/2252 0.97 (0.85–1.11) 157/514 1.07 (0.67–1.70)
40 646/2176 1.0 534/1734 1.0 31/107 1.0
NA 262/931 166/638 46/176
Pooled age
<30 1069/3364 1.05 (0.95–1.16) 1648/5370 1.11 (1.02–1.21) 883/2931 1.03 (0.85–1.25)
30 1115/3581 1.0 1190/3986 1.0 188/621 1.0
NA 262/931 166/638 46/176
Temporary dye†
Ever 211/631 1.38 (1.12–1.70) 275/851 1.27 (1.04–1.56) 87/244 1.27 (0.87–1.85)
Never 1298/3871 1.32 (1.13–1.54) 1895/6044 1.24 (1.06–1.46) 881/2854 1.15 (0.85–1.55)
Non-hair dye user 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 578/2076 560/2086 80/327
Semi-permanent dye
Ever 864/2520 1.39 (1.19–1.63) 1197/3798 1.25 (1.05–1.47) 463/1398 1.21 (0.89–1.65)
Never 884/2699 1.27 (1.08–1.49) 1224/3908 1.24 (1.05–1.46) 538/1822 1.11 (0.82–1.51)
Non-hair dye user; 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 339/1359 309/1275 47/205
Permanent dye
Ever 933/2918 1.24 (1.06–1.46) 1456/4741 1.23 (1.05–1.45) 670/2110 1.18 (0.87–1.59)
Never 889/2651 1.33 (1.13–1.56) 1046/3329 1.19 (1.01–1.41) 338/1200 1.08 (0.79–1.47)
Non-hair dye user 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 265/1009 228/911 40/115
Bleach
Ever 88/269 1.20 (0.90–1.61) 124/389 1.29 (1.00–1.67) 70/223 1.12 (0.75–1.67)
Never 1594/4805 1.32 (1.13–1.53) 2203/6989 1.24 (1.06–1.46) 908/2958 1.15 (0.86–1.56)
Non-hair dye user 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 405/1504 403/1603 70/244
Partial dye
Ever 620/1887 1.28 (1.08–1.52) 1027/3267 1.23 (1.04–1.46) 506/1532 1.25 (0.92–1.69)
(Continued)
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though Zheng et al. did not find an association between overall hair dye use and breast cancer,
the risk estimates for the use of semi-permanent dyes were consistently above 1 and also higher
compared to the estimates for the use of permanent hair dyes [17].
In a pooled analysis comparing ever and never-users of hair dyes, the odds ratio was the
highest in women born before 1950. This appears logical as they have had a possibility to
cumulate more hair dyeing episodes than their younger peers, for whom we might not yet see
the possible effect of hair dye use in breast cancer incidence. Odds ratios for cumulative hair
dye use, however, were the highest among women born between 1950 and 1959. If there is a
causal association between hair dye use and breast cancer and the length of the induction
period is assumed to be some 20–25 years, with our design, we are more likely to catch cases in
women of that age group. Cases born earlier or later than this, whose disease might have been
influenced by hair dye use, have already got their diagnosis before our ascertainment period
2000–2007, whereas the youngest cohort is still at risk. P-value from the likelihood test on the
heterogeneity between odds ratios for different age groups (P = 0.024) also suggests that expo-
sure over a long period of time carries a greater risk than short exposure.
Previous research on the association between hair dye use and risk of breast cancer has con-
cluded with somewhat mixed results. While the research groups of Nasca [18], Cook [19] and
Petro-Nustas [20] reported increased breast cancer risks in hair dye users, some studies have
ended up with no association [16, 21–23]. A meta-analysis on the association between hair dye
use and cancer risk concluded with a relative risk of 1.1 (95% CI: 0.9–1.2) for breast cancer, the
total number of study subjects, however, remaining fewer than in the present study [24]. Sup-
port to the results presented here is provided by the Nordic Occupational Cancer Study
(NOCCA), where the standardized incidence ratio obtained for breast cancer was 1.06 (1.01–
1.10) among a Nordic cohort of female hairdressers (N = 1983) [25], which naturally mainly
consisted of a somewhat similar study population, with respect to ethnicity.
As a retrospective study based on a self-administered questionnaire, our study is susceptible
to differential recall bias. The respondents might have found it difficult to estimate the total
number of hair dyes during their lifetime or to evaluate the types of dyes they have used and
breast cancer cases might also have over-estimated their hair dye use if they have had a pre-
sumption of its association with their disease. We see, however, no reason to expect much dif-
ference between cases and controls in reporting ever vs. never-use of hair dyes as hair coloring
is not commonly recognized as hazardous in regards to breast cancer. A reliability study by
Shore at al. estimated self-reported hair dye information to be of good quality, obtaining a
Table 4. (Continued)
Born before 1950 Born 1950–1959 Born 1960 or after
N: Ca 2446, Co 7876 N: Ca 3004, Co 9994 N: Ca 1117, Co 3728
Cases/Controls OR (CI 95%) Cases/Controls OR (CI 95%) Cases/Controls OR (CI 95%)
Never 1246/3750 1.32(1.13–1.54) 1493/4789 1.23 (1.05–1.45) 508/1773 1.04 (0.77–1.41)
Non-hair dye user 359/1298 1.0 274/1013 1.0 69/303 1.0
NA 221/941 210/925 34/120
* Odds ratios with 95% conﬁdence interval are reported, multivariate model adjusted for birth year, parity, age at ﬁrst birth, family history of breast cancer,
menarche age, use of hormonal contraceptives, physical activity, alcohol use, body mass index and level of education.
¥Women reporting using hair dyes ‘Never’ or ‘1–2 times’ in their lifetime were classiﬁed as never-users, all other categories counting as ever-users.
† Hair dye use according to the type of the dye was grouped into never and ever-users, answers ‘Rarely’ or ‘Never’ falling into category of never-users and
‘Often’ and ‘Quite often’ into ever-users. Non-users of hair dyes as deﬁned in pooled ever-use were used as a reference category.
doi:10.1371/journal.pone.0135190.t004
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correlation coefficient (r) 0.86 for duration of hair dye use from two telephone interviews one
year apart and the coefficients for cases and controls being almost similar [26].
It is still evident that we miss out cases with most aggressive types of cancer due to retro-
spective design. However, given the relatively similar diagnostic age distribution and the high
overall user prevalence of hair dyes, it is unlikely that missing of these cases would largely bias
the results. Also, results from the analysis including only cases from the last diagnostic years
suggest that recall bias is does not play a major role in the estimations. Concerning the poten-
tial role of national population based mammography screening, while 89% of the cases diag-
nosed before the age of 60 years had had their first mammogram before the diagnose, some
87% of the controls aged< 60 years at questionnaire had done so, suggesting no differences
between cases and controls in terms of screening attendance.
For further data-validation, we compared the distributions of age and education in the study
population to the figures obtained from the official statistics representing the general population
[27,28]. Questionnaire respondents were more often highly educated and older than women in
the general population. When 26% of women in Finland between the ages 22 and 64 years were
55 years of age or older, the corresponding percentage in the study population was 43%. The dif-
ference in education was largest among the youngest study participants, with 16 percentage
points more academically educated controls in the questionnaire, compared to that of the popu-
lation. Stratifying the analysis by age, adjusting for education and estimating bias-adjusted odd
ratios were one of the means in an effort to minimize the role of bias in the obtained results.
Some uncertainty, however, remains whether e.g. the inability to observe association in the
youngest age group is due bias or shorter period of time in possible disease latency.
To address for the role of recall bias, we estimated the level of differential misclassification
of the exposure. Even though we assumed there not to be major differences between cases and
controls in reporting whether or not they have ever used hair dyes, it is possible that more
unexposed cases have falsely classified themselves as exposed if they believed there to be a rela-
tionship between hair dye use and breast cancer. Thus in the sensitivity analysis, the sensitivity
was set to 90% for both cases and controls, whereas specificity among the cases was set to 80%
and to 90% regarding controls. The observed bias-adjusted odds ratio of 2.50 and 54% down-
ward bias imply that the results obtained in this study are highly sensitive to differential mis-
classification of the exposure. As stated, however, recall bias is not expected to have major
impact in reporting ever vs. never use of hair dyes, whereas the situation regarding the number
of dye episodes and different dye types is likely to be different and the level of uncertainty
could be higher.
The response rates in the questionnaire were 69% in cases and 55% among controls. Based
on this, we set the response probabilities with respect to hair dye exposure status in the sensitiv-
ity analysis to be 0.8 as for the exposed cases and 0.6 regarding non-exposed cases and corre-
spondingly 0.6 as of the exposed controls and 0.5 as of the non-exposed controls. The
probability was assumed to vary more among the cases whereas controls were likely to be more
homogenous in responding hair dye-related questions, regardless of their exposure status. The
estimated adjusted OR (1.04) implies that even if the response activity between the cases and
controls and between the exposed and unexposed was assumed to be rather heterogeneous, the
direction or the magnitude of the observed association does not majorly change.
As for uncontrolled confounding, socio-economic status was considered to be the most
probable source of such bias in our questionnaire. According to official population statistics
[28], on average 12% of the Finnish female population aged 25–65 years are academically edu-
cated and this figure was used as a prior when estimating the role of possible bias due to uncon-
trolled confounding. In the sensitivity analysis, the relative risk between high education (>16
years) and breast cancer was set to 1.36, as observed by Braaten et al. in 2004 [29]. The result of
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a bias-adjusted odds ratio of 1.46 with regards to uncontrolled confounding suggests that if the
percentage of academically educated women in the study population would match the one of
the general population—and given that education reliably serves as a proxy for socio-economic
status, the obtained odds ratio would have been 21% higher.
There has been evidence on current commercial hair dyes containing 4-ABP and contami-
nated PPD has been speculated as the source of it. In 2003, Turesky et al. [9] found adducts of
4-ABP in 8 out of 11 hair dye samples, whereas Akyüz & Ata detected similar contamination in
28 out of 54 samples of different commercial hair dyes and in 11 out of 25 henna samples [10].
These evidences are further validated by the study of Amborosone and colleagues, where ele-
vated levels of 4-ABP-DNA adducts were detected in the breast epithelial cells of hair dye users
[30]. Also an IARC working group on the assessment of 4-aminobiphenyl suggested that fre-
quent detection of 4-ABP adducts in non-smokers implies that there might be other environ-
mental sources of exposure, contaminated hair dye products potentially being one of them [6].
Smoking was left out from our analysis as the step-wise model search ranked it as a non-signifi-
cant variable. The observed odds ratios did not change when including smoking in the multi-
variate analysis, OR for ever-users of hair dye then being 1.22 (95% CI: 1.11–1.36, results not
shown).
Conclusions
Risk assessment in cosmetic industry is still largely self-regulated and lacks independent evalu-
ation. Safety reports are often provided by the stakeholders of the cosmetic industry [31]. Con-
sidering the popularity of hair coloring in the modern societies, the results obtained in our
study are worrying. Today, hair dyeing is an acceptable and essential part of beauty care and
do-it-yourself dyes are affordable and easy to use. Focus should be targeted on the safety of
commercial hair dyes and chemical substances they contain. Independent regulation and
research on a governmental and organizational level should be strengthened and manufactur-
ers of hair dye products ought to be provided with detailed guidelines and restrictions for
development and manufacture.
Our results suggest that increasingly popular use of hair coloring products may be substan-
tial in the etiology of new breast cancer cases. The study subjects, being permanent residents of
Finland, were likely to be mostly of Caucasian race. Considering the fairly blonde and homoge-
nous Finnish population, the results presented here may only be generalised to other western
societies with Caucasian majorities. Hair coloring habits and products in terms of dye types,
colors, and dye frequency are likely to differ between the cultures and ethnicities.
Even if the excess relative risk of breast cancer due to hair dye use is likely to be small at the
individual-level, taken the prevalence of the exposure into account, its impact on public health
can be considerable. We, however, acknowledge the limitations in retrospective study design
and further research with prospective design is warranted before making conclusive arguments
on the risks of hair dye use.
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